Amber Bio

CDMO focused on manufacturing generic drugs

placeSan Francisco, California, United States calendar_todayFounded 2021 groups9 employees language amber.bio

Innovation

9 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 104 times.

YearFilings
20245
20256
20261

Social engagement

Social engagement: 10.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Andreessen Horowitz.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Hiring activity

Hires occasionally

7 roles tracked across 1 of the last 12 months

20 Nov 2025 · Director, Nonclinical Development · San Mateo

5 Nov 2025 · Research Associate III/ Senior Research Associate (Biodesigner), Assay Development / Bioanalytical Development · Santa Rosa

5 Oct 2025 · High-Throughput Screening Research Associate II, III (Biodesigner II, III)

5 Oct 2025 · CMC Analytical Scientist (Bioarchitect) · Santa Rosa

Based on job postings tracked across public sources.

Recent activity

4 May 2026
Event
ASGCT 2026
Coming soon